247 related articles for article (PubMed ID: 11483849)
1. Disseminated vaccine strain varicella as the acquired immunodeficiency syndrome-defining illness in a previously undiagnosed child.
Kramer JM; LaRussa P; Tsai WC; Carney P; Leber SM; Gahagan S; Steinberg S; Blackwood RA
Pediatrics; 2001 Aug; 108(2):E39. PubMed ID: 11483849
[TBL] [Abstract][Full Text] [Related]
2. First case of vaccine-strain varicella infection as manifestation of HIV in healthcare worker: a case report and review of the literature.
Navalkele BD; Henig O; Fairfax M; Flanagan E; Upfal M; Russell J; Dhar S; Kaye K; Chopra T
J Hosp Infect; 2017 Dec; 97(4):384-388. PubMed ID: 28579471
[TBL] [Abstract][Full Text] [Related]
3. Varicella infection caused by Oka strain vaccine in a heart transplant recipient.
Kraft JN; Shaw JC
Arch Dermatol; 2006 Jul; 142(7):943-5. PubMed ID: 16847227
[No Abstract] [Full Text] [Related]
4. Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1.
Armenian SH; Han JY; Dunaway TM; Church JA
Pediatr Infect Dis J; 2006 Apr; 25(4):368-70. PubMed ID: 16567993
[TBL] [Abstract][Full Text] [Related]
5. Disseminated varicella infection caused by varicella vaccine strain in a child with low invariant natural killer T cells and diminished CD1d expression.
Banovic T; Yanilla M; Simmons R; Robertson I; Schroder WA; Raffelt NC; Wilson YA; Hill GR; Hogan P; Nourse CB
J Infect Dis; 2011 Dec; 204(12):1893-901. PubMed ID: 22043019
[TBL] [Abstract][Full Text] [Related]
6. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells.
Levy O; Orange JS; Hibberd P; Steinberg S; LaRussa P; Weinberg A; Wilson SB; Shaulov A; Fleisher G; Geha RS; Bonilla FA; Exley M
J Infect Dis; 2003 Oct; 188(7):948-53. PubMed ID: 14513412
[TBL] [Abstract][Full Text] [Related]
7. The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children.
Taweesith W; Puthanakit T; Kowitdamrong E; Bunupuradah T; Wongngam W; Phasomsap C; Apornpong T; Bouko C; Pancharoen C
Pediatr Infect Dis J; 2011 Apr; 30(4):320-4. PubMed ID: 20975615
[TBL] [Abstract][Full Text] [Related]
8. A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella.
Gershon AA; Levin MJ; Weinberg A; Song LY; LaRussa PS; Steinberg SP; Bartlett P;
Pediatr Infect Dis J; 2009 Jul; 28(7):653-5. PubMed ID: 19561431
[TBL] [Abstract][Full Text] [Related]
9. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1996 Jul; 45(RR-11):1-36. PubMed ID: 8668119
[TBL] [Abstract][Full Text] [Related]
10. Experience with live-attenuated varicella-zoster vaccines.
LaRussa P
Contrib Microbiol; 1999; 3():173-92. PubMed ID: 10599530
[No Abstract] [Full Text] [Related]
11. The safety profile of varicella vaccine: a 10-year review.
Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
[TBL] [Abstract][Full Text] [Related]
12. Live attenuated varicella vaccine.
Gershon AA
Annu Rev Med; 1987; 38():41-50. PubMed ID: 3034136
[TBL] [Abstract][Full Text] [Related]
13. Immunization of healthy adults with live attenuated varicella vaccine.
Gershon AA; Steinberg SP; LaRussa P; Ferrara A; Hammerschlag M; Gelb L
J Infect Dis; 1988 Jul; 158(1):132-7. PubMed ID: 2839577
[TBL] [Abstract][Full Text] [Related]
14. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Marin M; Güris D; Chaves SS; Schmid S; Seward JF;
MMWR Recomm Rep; 2007 Jun; 56(RR-4):1-40. PubMed ID: 17585291
[TBL] [Abstract][Full Text] [Related]
15. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
17. Study of tolerance and effectiveness of a varicella vaccine in leukemic children.
Bancillon A; Leblanc T; Baruchel A; Schaison G; Leverger G; Mallarmey D; Teuliere L
Nouv Rev Fr Hematol (1978); 1991; 33(6):555-6. PubMed ID: 1667953
[TBL] [Abstract][Full Text] [Related]
18. Current status and prospects of live varicella vaccine.
Takahashi M
Vaccine; 1992; 10(14):1007-14. PubMed ID: 1335196
[TBL] [Abstract][Full Text] [Related]
19. Vaccine-Strain Varicella Virus Transmitted to a Term Infant Following Maternal Postpartum Vaccination.
Saringkarisate K; Len KA; Melish ME; Prothero BK; Ching N
J Pediatric Infect Dis Soc; 2022 Oct; 11(10):452-453. PubMed ID: 35751631
[TBL] [Abstract][Full Text] [Related]
20. Human immune responses to live attenuated varicella vaccine.
Gershon AA
Rev Infect Dis; 1991; 13 Suppl 11():S957-9. PubMed ID: 1664134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
